Jennifer Shanley provides health regulatory counsel to a range of industry clients, including pharmaceutical and biologic manufacturers, health systems, hospitals, provider practice groups, skilled nursing facilities, home care agencies, clinical laboratories, pharmacies, health insurers, charitable foundations and companies that invest in the health industry.

Download full bio 


  • Lyell Immunopharma – $425 Million IPO 

  • Olive Closes $225 Million Financing, Acquires Verata Health 

  • Opthea – $128 Million IPO 

  • ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal 

  • Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy 

  • View all


  • Fordham University School of Law
    JD, 2010

  • Georgetown University
    BS, Health Care Management and Policy (Major), International Health (Certificate)
    magna cum laude, 2007

Admissions & Credentials

New York

New Jersey

Rankings & Accolades

    Best Lawyers: Ones to Watch in Healthcare Law (2021)